Experience in the use of low-dosed levonorgestrel-containing intrauterine system LCS16 and combined oral contraceptive containing 30 mcg ethinyl estradiol and 3 mg drospirenone in young women
- Authors: Suturina L.V.1, Dikke G.B.2
-
Affiliations:
- Scientific Center for Family Health and Human Reproduction Problems
- F.I. Inozemtsev Academy of Medical Education
- Issue: No 11 (2021)
- Pages: 230-236
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249541
- DOI: https://doi.org/10.18565/aig.2021.11.230-236
- ID: 249541
Cite item
Abstract
Objective: To assess the satisfaction of young nulliparous and parous women using low-dosed levonorgestrel-releasing intrauterine system (LNG-IUS) or taking a combined oral contraceptive (COC) containing 30 mcg ethinyl estradiol and 3 mg drospirenone for 12 months. Materials and methods: The study included women aged 18-29 years (n=147) who used LNG-LUS LCS16 (n=74) or took COC (30 mcg ethinyl estradiol and 3 mg drospirenone) (n=73). We studied general satisfaction of the patients using the contraceptive method and the Likert scale 6 and 12 months after applying one of the contraception methods. We assessed the satisfaction using the bleeding and pain profile, treatment-emergent adverse events (TEAE), preferences in contraception method and attrition rate. Results: The percentage of patients who considered themselves to be ‘very satisfied’ and ‘satisfied’ with the contraception method was 90.3% (65/72) in the group using the LUD, and 97.3% (71/73) in the group taking the COC for 12 months. There was a decrease in bleeding and pain when patients used both methods and a decrease in the number of days of blood loss in the LUD group after 12 months. Amenorrhea was observed in 7.7% (5/72) of the participants of the LUD group and in no cases in the COC group. The patients’ responses about the bleeding profile were ‘very satisfied’ or ‘rather satisfied’ in 94.3% (66/72) and 95.8% (69/73) of the cases, respectively. TEAE were revealed in 50% (36/72) of women in the LNG-LUS group and in 38.4% (28/73) of women in the COC group. After 12 months, 81.4% and 79.2% (57/73) women respectively wanted to continue using their method of contraception. Conclusion: Both contraception methods, LNG-LUS and COC, are characterized by high satisfaction rates.
Full Text
About the authors
Larisa V. Suturina
Scientific Center for Family Health and Human Reproduction Problems
Email: lsuturina@mail.ru
Dr. Med. Sci., Professor, Chief Researcher, Head of the Department of Reproductive Health Protection
Galina B. Dikke
F.I. Inozemtsev Academy of Medical Education
Email: galadikke@yandex.ru
Dr Med. Sci., Associate Professor, Professor of the Department of Obstetrics and Gynecology with a course of reproductive medicine
References
- Sedgh G., Singh S., Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud. Fam. Plann. 2014; 45(3): 301-14. https://dx.doi.org/10.1111/j.1728-4465.2014.00393.x.
- Federal State Statistics Service (ROSSTAT). Ministry of Health of the Russian Federation. Information and Publishing Center “Statistics of Russia”. Russia Reproductive Health Survey 2011. Executive summary. 2012.
- Федеральная служба государственной статистики. Здравоохранение в России. Статистический сборник. Росстат. М.; 2017. 170с. Доступно по: http://www.gks.ru/free_doc/doc_2017/zdrav17.pdf
- Montouchet C., Trussell J. Unintended pregnancies in England in 2010: costs to the National Health Service (NHS). Contraception. 2013; 87(2): 149-53. https://dx.doi.org/10.1016/j.contraception.2012.06.008.
- Finer L.B., Zolna M.R. Shifts in intended and unintended pregnancies in the United States, 2001-2008. Am. J. Public Health. 2014; 104(Suppl. 1): S43-8. https://dx.doi.org/10.2105/AJPH.2013.301416.
- Mosher W.D., Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat. 23. 2010; (29): 1-44.
- Trussell J. Contraceptive failure in the United States. Contraception. 2011; 83(5): 397-404. https://dx.doi.org/10.1016/j.contraception.2011.01.021.
- NICE. National Institute for Health and Care Excellence. Long-acting reversible contraception (LARC). Clinical guideline. 2005. Available at: https://www.nice.org.uk/guidance/cg30
- ACOG Committee Opinion No. 735: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet. Gynecol. 2018; 131(5): e130-e139. https://dx.doi.org/10.1097/AOG.0000000000002632.
- Committee Opinion No. 642: increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet. Gynecol. 2015; 126(4): e44-e48. https://dx.doi.org/10.1097/A0G.0000000000001106.
- Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group. Practice Bulletin No. 186: long-acting reversible contraception: implants and intrauterine devices. Obstet. Gynecol. 2017; 130(5): e251-e269. https://dx.doi.org/10.1097/AOG.0000000000002400.
- Lohr P.A., Lyus R., Prager S. Use of intrauterine devices in nulliparous women. Contraception. 2017; 95(6): 529-37. https://dx.doi.org/10.1016/j.contraception.2016.08.011.
- WНО Guidelines Approved by the Guidelines Review Committee. Medical eligibility criteria for contraceptive use. 5th ed. Geneva: World Health Organization; 2015.
- Heinemann K., Reed S., Moehner S., Minh T.D. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: The European Active Surveillance Study for Intrauterine Devices. Contraception. 2015; 91(4): 280-3. https://dx.doi.org/10.1016/j.contraception.2015.01.011.
- Кузнецова И.В. Выбор комбинированной оральной контрацепции для подростков и молодых женщин. Акушерство и гинекология. 2018; 1: 35-40. [Kuznetsova I.V. Choice of combined oral contraception for adolescent girls and young women. Obstetrics and Gynecology. 2018; 1: 35-40. (in Russian)]. https://dx.doi.org/10.18565/aig.2018.1.35-40.
- Довлетханова Э.Р., Мгерян А.Н., Абакарова П.Р. Вопросы приемлемости и безопасности при выборе комбинированных оральных контрацептивов. Акушерство и гинекология. 2019; 4: 79-86. [Dovletkhanova E.R., Mgeryan A.N., Abakarova P.R. Issues of acceptability and safety when choosing combined oral contraceptives. Obstetrics and Gynecology. 2019; 4: 79-86. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.4.79-86.
- Gemzell-Danielsson K., Apter D., Dermout S., Faustmann T., Rosen K., Schmelter T. et al. Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017; 210: 22-8. https://dx.doi.org/10.1016/j.ejogrb.2016.11.022.
- Hall A.M., Kutler B.A. Intrauterine contraception in nulliparous women: a prospective survey. J. Fam. Plann. Reprod. Health Care. 2016; 42(1): 36-42. https://dx.doi.org/10.1136/jfprhc-2014-101046.
- Black A., Guilbert E., Costescu D., Dunn S., Fisher W., Kives S. et al. Canadian Contraception Consensus (Part 3 of 4): Chapter 7 - Intrauterine contraception. J. Obstet. Gynaecol. Can. 2016; 38(2): 182-222. https://dx.doi.org/10.1016/j.jogc.2015.12.002.
- Ассоциация организаций по клиническим исследованиям. Хельсинкская декларация Всемирной медицинской ассоциации. Принята на 18-й Генеральной Ассамблее ВМА, Хельсинки, Финляндия, июнь 1964 г., изменения внесены на 64-й Генеральной Ассамблее ВМА, Форталеза, Бразилия, октябрь 2013 г.
- Федеральное агентство по техническому регулированию и метрологии. Национальный стандарт Российской Федерации. ГОСТ Р. 523792005. Надлежащая клиническая практика. Официальное издание. М.: Стандартинформ; 2006. 39с.
- Nelson A.L., Apter D., Hauck B., Schmelter T., Rybowski S., Rosen K. et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet. Gynecol. 2013; 122(6): 1205-13. https://dx.doi.org/10.1097/AOG.0000000000000019.
- Beatty M.N., Blumenthal P.D. The levonorgestrel-releasing intrauterine system: safety, efficacy, and patient acceptability. Ther. Clin. Risk Manag. 2009; 5(3): 561-74. https://dx.doi.org/10.2147/tcrm.s5624.
- Gemzell-Danielsson K., Ink P., Heikinheimo O. Safety and efficacy of the levonorgestrel-releasing intrauterine system. Expert Rev. Obstet. Gynecol. 2013; 8(3): 235-47. https://dx.doi.org/10.1586/eog.13.18.
- Borgatta L., Buhling K.J., Rybowski S., Roth K., Rosen K. A multicentre, open-label, randomized phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age. Eur. J. Contracept. Reprod. Health Care. 2016; 21(5): 372-9. https://dx.doi.org/10.1080/13625187.2016.1212987.
- Прилепская В.Н., Абакарова П.Р., Межевитинова Е.А., Довлетханова Э.Р., Назарова Н.М. Современные принципы консультирования в контрацепции. Гормональная контрацепция. Акушерство и гинекология. 2021; 3(Приложение): 17-22.
- Stephenson J., Shawe J., Panicker S., Brim a N., Cop as A., Sauer U. et al. Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year. Contraception. 2013; 88(4): 523-31. https://dx.doi.org/10.1016/j.contraception.2013.03.014.
- Berenson A.B., Rahman M. A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms. Contraception. 2012; 86(6): 716-24. https://dx.doi.org/10.1016/j.contraception.2013.03.014.